The role of nitric oxide in the pathogenesis of pulmonary arteriovenous malformations in children with congenital cyanotic heart disease.

被引:0
|
作者
Do, KD
Duncan, BW
Starnes, SL
Kneebone, JM
机构
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Childrens Hosp & Reg Med Ctr, Dept Cardiothorac Surg, Seattle, WA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
325
引用
收藏
页码:60A / 60A
页数:1
相关论文
共 50 条
  • [21] Oral ketamine for pre-operative sedation in children with congenital cyanotic heart disease.
    Saxena, N
    Kiran, U
    Sehra, S
    ANESTHESIA AND ANALGESIA, 1997, 84 : S449 - S449
  • [22] Bubble contrast echocardiography in defecting pulmonary arteriovenous malformation in children with cyanotic heart disease
    Chang, RKR
    Atkinson, D
    Jensen, R
    Drant, S
    Laks, H
    Alejos, JC
    CIRCULATION, 1998, 98 (17) : 618 - 618
  • [23] The effect of nebulised epoprostenol on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease.
    Forrest, IA
    Small, T
    Corris, PA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A158 - A158
  • [24] Role of leptin and Insulin like growth Factor-1 In regulation of growth in children with congenital cyanotic heart disease.
    Elsharkawy, Ashraf A.
    El-Hawary, Amany K.
    Alsawah, Gehan A.
    Aboelenin, Hadil M.
    Awad, Mohammad H.
    GROWTH FACTORS, 2024, 42 (04) : 198 - 204
  • [25] Pathogenesis of pulmonary arteriovenous malformations: role of hepatopulmonary interactions.
    Vettukattil, JJ
    HEART, 2002, 88 (06) : 561 - 563
  • [26] Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
    Bizzarro, Matthew
    Gross, Ian
    Barbosa, Fabiano T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [27] Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
    Bizzarro, M.
    Gross, I
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [28] Modifier genes in the pathogenesis of congenital heart disease.
    Kaiser, K
    Takematsu, M
    Jay, P
    PEDIATRIC RESEARCH, 2005, 58 (04) : 818 - 818
  • [29] Endogenous nitric oxide production in children with congenital heart disease
    Kaine, SF
    Reinsvold, PF
    Norberg, MI
    Truog, WE
    PEDIATRIC RESEARCH, 2000, 47 (04) : 45A - 45A
  • [30] Cerebral abscess in children with cyanotic congenital heart disease
    Baysal, K
    Ozturk, F
    Uysal, S
    Sancak, R
    Gurses, N
    CARDIOLOGY IN THE YOUNG, 1997, 7 (04) : 383 - 387